É. Sbidian

157 papers receiving 3.7k citations

É. Sbidian's Hit Papers

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database 2022 · 111 citations
1110+1+2Years since publication255075100

Peers

É. Sbidian
Comparison fields: 5 of 123
  • Dermatology 800
  • Immunology 1.4k
  • Rheumatology 593
  • Neurology 347
  • Pathology and Forensic Medicine 397
Replace Clara De Simone with:
Clara De Simone Italy
Andrea L. Neimann United States
Giuseppe Murdaca Italy
R.J.G. Chalmers United Kingdom
Bárður Sigurgeirsson Iceland
Moisés Labrador‐Horrillo Spain
I. García‐Doval Spain
Stefano Piaserico Italy
Rohit Aggarwal United States
Rokea A. el‐Azhary United States
É. Sbidian relative to Clara De Simone Italy Clara De Simone's profile →
Citations per field
00.5×7.2×
Clara De Simone · 1×
Citations per year

Countries citing papers authored by É. Sbidian

Since Specialization
Citations

This map shows the geographic impact of É. Sbidian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Sbidian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Sbidian more than expected).

Fields of papers citing papers by É. Sbidian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Sbidian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Sbidian. The network helps show where É. Sbidian may publish in the future.

Co-authors

The 25 scholars most cited alongside É. Sbidian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with É. Sbidian Line = papers co-authored together É. Sbidian links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 172 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2017339
2 2011135
3 2020129
4
Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database
Hit paper breakdown →
2022111
5 2011104
6 202199
7 201889
8 202288
9 202285
10 202082
11 201180
12 201674
13 201373
14 201373
15 202172
16 201369
17 201568
18 202165
19 202363
20 201159

About É. Sbidian

É. Sbidian is a scholar working on Immunology, Rheumatology, Dermatology, Public Health, Environmental and Occupational Health and Pharmacology, having authored 172 papers that have together received 3.7k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (48 papers), Drug-Induced Adverse Reactions (16 papers), Neurofibromatosis and Schwannoma Cases (13 papers), Autoimmune Bullous Skin Diseases (13 papers), Streptococcal Infections and Treatments (11 papers), Dermatology and Skin Diseases (11 papers), Spondyloarthritis Studies and Treatments (9 papers) and Hidradenitis Suppurativa and Treatments (8 papers). The work is most often cited by research in Dermatology (800 citations), Immunology (1.4k citations), Rheumatology (593 citations), Neurology (347 citations) and Pathology and Forensic Medicine (397 citations). É. Sbidian has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include O. Chosidow, Laurence Le Cleach, Camille Hua, P. Wolkenstein, Carolyn Hughes, Anna Chaimani, I. García‐Doval, Luigi Naldi, Laëtitia Penso and Laura Pina Vegas. Their work appears in journals such as British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology, Cochrane Database of Systematic Reviews, Dermatology and JAMA Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact